Yuki Kagiyama¹, Shuhei Fujita¹, Makoto Nakagawa¹, Daisuke Honma², Nobuaki Adachi², Kazushi Araki², Ayako Kato³, Koichiro Inaki³, Yoshimasa Ono³, Suguru Fukuhara⁴, Yukio Kobayashi⁴, Kensei Tobinai⁴, Issay Kitabayashi¹ (1.Hematological Malignancy, Natl. Cancer Ctr. Res. Inst., Tokyo, Japan, 2.Oncol. Lab., Daiichi Sankyo, Tokyo, Japan, 3.Disc. Sci. & Tech. Dept., Daiichi Sankyo RD Novare, Tokyo, Japan, 4.Dept. of Hematol., Natl. Cancer Ctr. Hosp, Tokyo, Japan)

Tomonaga Ichikawa, Shingo Nakahata, Kazuhiro Morishita (Tumor and Cellular Biochemistry, University of Miyazaki)

Tatsuro Watanabe¹, Hiroshi Ureshino¹, Yuki Kurahashi^1,2, Satoshi Yamashita³, Toshikazu Ushijima³, Eisaburo Sueoka⁴, Shinya Kimura^1,5 (1.Drug Discov. and Biomed. Sci., Saga Univ., Saga, Japan, 2.OHARA Pharmaceutical Co., Ltd., Shiga, Japan, 3.Div. Epigenomics, Natl. Cancer Ctr. Res. Inst., Tokyo, Japan, 4.Dept. Clin. Lab. Med., Saga Univ., Saga, Japan, 5.Dept. Hematology, Respiratory Medicine and Oncology, Saga Univ., Saga, Japan)

Hiroyuki Matsui¹, Kotaro Shirakawa¹, Hsin-Yi Chang², Sarca. A. Daniela¹, Yasuhiro Kazuma¹, Hirofumi Fukuda¹, Hiroyuki Yamazaki¹, Tadahiko Matsumoto¹, Yasushi Ishihama², Akifumi Takaori-Kondo¹ (1.Dept. Hematology and Oncology, Grad. Sch. Med., Kyoto Univ., 2.Lab. Molecular and Cellular Bioanalysis, Grad. Sch. Pharm., Kyoto University)

Taku Tsukamoto¹, Shingo Nakahata², Ryuichi Sato³, Akinori Kanai⁴, Masakazu Nakano³, Toshiya Inaba⁴, Masafumi Taniwaki¹, Kei Tashiro³, Kazuhiro Morishita², Junya Kuroda¹ (1.Hematology and Oncology, Kyoto Prefectural Univesity of Medicine, Kyoto, Japan, 2.Tumor and Cellular Biochemistry, University of Miyazaki, Miyazaki, Japan, 3.Genomic Medical Sciences, Kyoto Prefectural University of Medicine, Kyoto, Japan, 4.Molecular Oncology, RIRBM, Hiroshima University, Hiroshima, Japan)

Tomoko Takimoto-Shimomura, Taku Tsukamoto, Saori Maegawa, Yoshiaki Chinen, Yuji Shimura, Shigeo Horiike, Tsutomu Kobayashi, Junya Kuroda (Hematology and Oncology, Kyoto Prefectural University, Kyoto, Japan)